| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |